Thyroid Cancer: Clinical Trials

418 trials for Thyroid Cancer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

168 completed, 82 recruiting, 76 unknown, 30 active not recruiting. 115 Not applicable, 96 Phase 2, 39 Phase 1, 18 Phase 3, 9 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable115Completed 41, Unknown 33, Recruiting 20, Not yet recruiting 10, Terminated 4, Active not recruiting 3, Withdrawn 2, Enrolling by invitation 1, Suspended 1
Phase 296Completed 40, Recruiting 17, Unknown 13, Active not recruiting 10, Terminated 8, Not yet recruiting 6, Suspended 1, Withdrawn 1
Phase 139Completed 16, Recruiting 7, Terminated 5, Active not recruiting 4, Not yet recruiting 3, Unknown 2, Withdrawn 2
Phase 318Recruiting 8, Completed 7, Active not recruiting 2, Unknown 1
Phase 49Completed 5, Recruiting 2, Terminated 2
Early Phase 13Active not recruiting 1, Completed 1, Recruiting 1

Follow Thyroid Cancer: new trials by email Literature Review of Thyroid Cancer trials Research Report on Thyroid Cancer

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Mapping Patient Decision-making in Thyroid Cancer
Decision navigation tool - Thyroid Cancer
Not applicableNot yet recruitingUniversity of California, Los Angeles502028-04-012026-07-24
Pre-Clinic Visit Online Education for Thyroid Cancer
THRIVE, ACS "After a Thyroid Cancer Diagnosis" Flyer - Thyroid Cancer
Not applicableNot yet recruitingCedars-Sinai Medical Center602027-08-012026-09-01
Pulsed Stereotactic Ablative Radiotherapy (PULSAR) With Systematic Therapy for Thyroid Cancer
Dabrafenib, Trametinib, Pembrolizumab - Anaplastic Thyroid Carcinoma, Thyroid Cancer
Phase 2Not yet recruitingWashington University School of Medicine122026-12-312026-10-21
177Lu-DOTA-EB-TATE in Adult Patients With Metastatic, Radioactive Iodine Non-Responsive Oncocytic (Hurthle-Cell) Thyroid Cancer
68Ga-DOTA-TATE PET Scan, Amino acid infusions, 177Lu-DOTA-EB-TATE - Thyroid Cancer
Phase 1 / Phase 2Not yet recruitingNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)182026-11-172026-11-12
Serum Treg/Th17-Related Cytokines and Systemic Inflammatory Indices in Differentiated Thyroid Cancer
Differentiated Thyroid Cancer (DTC), Papillary Thyroid Carcinoma
Not yet recruitingMarmara University902026-11-012026-11-02
Educational Videos for Thyroid Surgery Patient
Thyroid Surgery Educational Video - Thyroid Cancer, Thyroid Nodule
Not applicableNot yet recruitingWest China Hospital4002026-10-012026-09-16
Head and Neck Cancer Strategies
Head and Neck Cancer (H&N), Thyroid Cancer
Enrolling by invitationAarhus University Hospital15002026-10-012026-11-02
MRG003 Added to Ongoing Treatment After Progression in EGFR-Positive Advanced Thyroid Cancer
Becotatug Vedotin (MRG003), Lenvatinib, Anti-PD-1 Inhibitor (Continuation of Prior Treatment) - Thyroid Cancer, Tumor
Phase 2RecruitingSun Yat-Sen Memorial Hospital of Sun Yat-Sen University392026-09-202026-10-14
Pattern and Surgical Outcome of Papillary Thyroid Cancer at Sohag University Hospitals
Papillary Thyroid Carcinoma, Thyroid Cancer
Not yet recruitingSohag University302026-09-162026-09-16
Effectiveness of WeChat-Supported Neck Rehabilitation Exercises on Early Recovery After Thyroidectomy
WeChat-supported Neck Rehabilitation Exercise, Standardized Postoperative Care and Video Education - Thyroid Diseases, Thyroid Cancer
Not applicableRecruitingShanghai 6th People's Hospital2002026-09-092026-09-10
Thyroid Health Outcomes Registry for Surgery
Thyroid Diseases, Thyroid Neoplasms
Not yet recruitingPirogov Russian National Research Medical University30002026-09-012026-09-10
Thyroid Hormone Replacement After Radio Iodine: Value and Efficacy
Euthyrox (levothyroxine), Cytomel (liothyronine) - Differentiated Thyroid Cancer, Thyroid Cancer
Not yet recruitingUniversity Medical Center Groningen402026-09-012026-02-10
Selective Coverage Versus Comprehensive Coverage Radiotherapy in Poorly Differentiated and Anaplastic Thyroid Cancer
Selective coverage radiotherapy, comprehensive coverage radiotherapy - Thyroid Cancer
Phase 2RecruitingFudan University722026-08-122026-08-20
Trophoblast Cell-Surface Antigen 2 (Trop-2) Targeted PET/CT in Recurrent and Metastatic Thyroid Cancer
Compared the diagnostic performance of 68Ga-MY6349 PET/CT with 68Ga-FAPI PET/CT - Tumor, Solid Tumor
Not applicableRecruitingThe First Affiliated Hospital of Xiamen University1202026-08-012026-08-07
FAPI PET Imaging - An Exploratory Study
[18F]FAPI-74 PET/CT - Thyroid Pathology, Head and Neck Cancer (H&N)
Phase 1 / Phase 2Not yet recruitingMartin Huellner7702026-08-012026-07-15
Integrating Tumor Genomics and Urinary Exosomal Proteomics to Establish a Multi-Layer Biomarker Framework for Early Risk Stratification and Post-Treatment Surveillance in Fresh Thyroid Cancer Patients
Genomics, Thyroid Cancer
Not yet recruitingNational Taiwan University Hospital1002026-08-012026-04-20
Clinical Study on the Efficacy of Laparoscopic Assisted Open Surgery Through Subclavian Approach for Unilateral Thyroid Cancer
Thyroid Cancer
Not yet recruitingXijing Hospital4002026-07-012026-06-17
A Study of Meaning-Centered Therapy for Mexican Adults With Advanced Cancer
Meaning-Centered Psychotherapy for Latinos /MCP-L - Breast Cancer, Prostate Cancer
Not applicableRecruitingMemorial Sloan Kettering Cancer Center3002026-05-012026-08-03
The Safety, Dosimetry and Efficacy of 177Lu-INN805 in Patients With Malignant Solid Tumors
INN805 - Maligant Solid Tumor, Head & Neck Cancer
Early Phase 1RecruitingFindCure Biosciences (ZhongShan) Co., Ltd.102026-04-202026-09-04
Ganoderma Spores Modulate the Gut-Brain Axis
Sporoderm-removed Ganoderma lucidum spore powder (RGLS), Placebo - Depression, Thyroid Cancer
Not applicableCompletedLing Zhiqiang3002026-04-112026-08-28

Showing 20 of 418. Sign in to see all of them.

Narrower conditions

Thyroid Neoplasms (418)  ·  Thyroid Nodule (48)  ·  Breast Neoplasms (39)  ·  Thyroid Diseases (36)  ·  Prostatic Neoplasms (29)  ·  Thyroid Cancer, Papillary (25)  ·  Head and Neck Neoplasms (24)  ·  Lung Neoplasms (23)  ·  Ovarian Neoplasms (23)  ·  Melanoma (22)  ·  Neoplasms (22)  ·  Pancreatic Neoplasms (22)  ·  Stomach Neoplasms (22)  ·  Sarcoma (20)  ·  Colonic Neoplasms (18)

Broader conditions

Endocrine System Diseases (418)  ·  Neoplasms by Site (418)  ·  Endocrine Gland Neoplasms (416)  ·  Neoplasms (396)  ·  Head and Neck Neoplasms (394)  ·  Thyroid Diseases (382)  ·  Neoplasms by Histologic Type (96)  ·  Neoplasms, Glandular and Epithelial (77)  ·  Carcinoma (69)  ·  Adenocarcinoma (54)  ·  Pathological Conditions, Signs and Symptoms (54)  ·  Skin Diseases (54)  ·  Skin and Connective Tissue Diseases (54)  ·  Respiratory Tract Diseases (52)  ·  Digestive System Diseases (49)

Interventions

Iodine-131 (12)  ·  lenvatinib (11)  ·  Thyroxine (8)  ·  pembrolizumab (8)  ·  trametinib (8)  ·  Surgical Procedures, Operative (6)  ·  Thyrotropin Alfa (6)  ·  dabrafenib (6)  ·  Biopsy, Fine-Needle (5)  ·  Sorafenib (5)  ·  vandetanib (5)  ·  Biopsy (4)  ·  Everolimus (4)  ·  anlotinib (4)  ·  Biopsy, Large-Core Needle (3)

Sponsors

Memorial Sloan Kettering Cancer Center (21)  ·  Fudan University (13)  ·  National Cancer Institute (NCI) (9)  ·  Fujian Medical University (7)  ·  Assiut University (6)  ·  National Taiwan University Hospital (6)  ·  Yonsei University (6)  ·  Dana-Farber Cancer Institute (5)  ·  Eisai Inc. (5)  ·  National Cancer Center, Korea (5)  ·  National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (5)  ·  Genzyme, a Sanofi Company (4)  ·  Gustave Roussy, Cancer Campus, Grand Paris (4)  ·  M.D. Anderson Cancer Center (4)  ·  Seoul National University Hospital (4)

Countries

United States (135)  ·  China (82)  ·  France (33)  ·  South Korea (31)  ·  Italy (28)  ·  United Kingdom (19)  ·  Canada (18)  ·  Spain (17)  ·  Denmark (16)  ·  Australia (11)  ·  Taiwan (11)  ·  Turkey (Türkiye) (11)  ·  Belgium (10)  ·  Netherlands (10)  ·  Germany (9)

Top investigators

Kiyohiko Mabuchi, M.D. (4)  ·  Alan Ho, MD, PhD (3)  ·  Douglas Van Nostrand, MD (3)  ·  Eric Sherman, MD (3)  ·  Joanna Klubo-Gwiezdzinska, M.D. (3)  ·  Alan L Ho, MD, PhD (2)  ·  Eun Kyung Lee (2)  ·  Kartik Seghal, MD (2)  ·  Kate Newbold (2)  ·  Ling Zhan, Doctor (2)  ·  Naykky Singh Ospina (2)

Results publications

PMID 32612576, PMID 40668552, PMID 11442004, PMID 11875733, PMID 12225640, PMID 12541136, PMID 12800205, PMID 15068625, PMID 15551359, PMID 15588952, PMID 15855141, PMID 16384850, PMID 17299648, PMID 18323549, PMID 18469262, PMID 18596272, PMID 19022998, PMID 19158200, PMID 19773371, PMID 20484486, PMID 20739388, PMID 21547389, PMID 22025146, PMID 22298862, PMID 22479375, PMID 22521260, PMID 22551127, PMID 22753906, PMID 22956016, PMID 23009127, PMID 23073921, PMID 23155345, PMID 23406027, PMID 23990665, PMID 24002501, PMID 24449746, PMID 24768486, PMID 25086465, PMID 25581596, PMID 25671254, PMID 25860987, PMID 26041482, PMID 26088605, PMID 26163763, PMID 26195199, PMID 26426092, PMID 26511519, PMID 26597705, PMID 26795614, PMID 27070179

NIH funding

2014 (2), 2016 (2), K08CA248972 (2), 1UG3CA297705-01A1 (1), 2005 (1), 2015 (1), 2018 (1), 2019 (1), 2025 (1), 4UH3DE031248-03 (1), K08CA230204 (1), P01CA229997 (1), P30CA046934 (1), R01CA212147 (1), R01CA220681 (1)